Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer
15. Mai 2023 07:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer Arun is an award-winning engineer who brings over 15 years’ experience in leading the design and development of...
Indigo Diabetes Business Update
04. Januar 2023 07:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Diabetes Business Update SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trialSeveral key senior appointments made in...
Indigo Diabetes Business Update
04. Januar 2023 01:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Diabetes Business Update SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trialSeveral key senior appointments made in...
Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.
27. Oktober 2022 07:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc. Indigo establishes a US presence to drive business...
Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.
27. Oktober 2022 01:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc. Indigo establishes a US presence to drive business...
Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial
29. September 2022 07:00 ET
|
Indigo Diabetes N.V.
Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial BELGIUM – Ghent, September 29, 2022 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of...
Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial
29. September 2022 03:00 ET
|
Indigo Diabetes N.V.
Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial BELGIUM – Ghent, September 29, 2022 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of...
Indigo Diabetes Business Update
21. Dezember 2021 07:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Diabetes Business Update BELGIUM – Ghent, December 21, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics,...
Indigo Diabetes Business Update
21. Dezember 2021 02:00 ET
|
Indigo Diabetes N.V.
PRESS RELEASE Indigo Diabetes Business Update BELGIUM – Ghent, December 21, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics,...
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board
12. Mai 2021 07:00 ET
|
Indigo Diabetes N.V.
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board Brings decades of leadership experience in the Global MedTech sector As CEO of ConvaTec Group Plc, led the $4.5 billion IPO on the...